1.2 interaction as a therapeutic target for attenuating pathogenic hyperexcitability in early-stage AD.
No takes yet. Share an insight, caveat, or question.
Dvorak et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: